SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-21-119002
Filing Date
2021-09-24
Accepted
2021-09-24 06:06:39
Documents
2
Group Members
C-BRIDGE CAPITAL GP, LTD.C-BRIDGE HEALTHCARE FUND GP, L.P.C-BRIDGE HEALTHCARE FUND, L.P.WEI FU

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2128324d1_sc13g.htm SC 13G 99020
2 EXHIBIT 1 tm2128324d1_ex1.htm EX-99.1 7714
  Complete submission text file 0001104659-21-119002.txt   108570
Mailing Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062
Business Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062 (847) 562-4300
Clarus Therapeutics Holdings, Inc. (Subject) CIK: 0001817944 (see all company filings)

IRS No.: 851231852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91924 | Film No.: 211273990
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address TWO EXCHANGE SQUARE, 8 CONNAUGHT PLACE SUITES 3306-3307 CENTRAL K3 00000
Business Address TWO EXCHANGE SQUARE, 8 CONNAUGHT PLACE SUITES 3306-3307 CENTRAL K3 00000 86 21 8012 1275
CBC SPVI Ltd (Filed by) CIK: 0001884569 (see all company filings)

IRS No.: 981426267 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13G